RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • SCIESCOPUSKCI등재

        Aspirin resistance as cardiovascular risk after kidney transplantation

        Sandor, Barbara,Varga, Adam,Rabai, Miklos,Toth, Andras,Papp, Judit,Toth, Kalman,Szakaly, Peter 한국유변학회 2014 Korea-Australia rheology journal Vol.26 No.2

        International surveys have shown that the leading cause of death after kidney transplantation has cardiovascular origin with a prevalence of 35-40%. As a preventive strategy these patients receive aspirin (ASA) therapy, even though their rate of aspirin resistance is still unknown. In our study, platelet aggregation measurements were performed between 2009 and 2012 investigating the laboratory effect of low-dose aspirin (100 mg) treatment using a CARAT TX4 optical aggregometer. ASA therapy was considered clinically effective in case of low (i.e., below 40%) epinephrine-induced ($10{\mu}M$) platelet aggregation index. Rate of aspirin resistance, morbidity and mortality data of kidney transplanted patients (n = 255, mean age: $49{\pm}12$ years) were compared to a patient population with cardio- and cerebrovascular diseases (n = 346, mean age: $52.6{\pm}11$ years). Rate of aspirin resistance was significantly higher in the renal transplantation group (RT) compared to the positive control group (PC) (35.9% vs. 25.6%, p < 0.002). Morbidity analysis demonstrated significantly higher incidence of myocardial infarction, hypertension and diabetes mellitus in the RT group (p < 0.05). The subgroup analysis revealed significantly higher incidence of infarction and stroke in the ASA resistant RT group compared to the RT patients without ASA resistance (p < 0.05). Furthermore, the incidence of myocardial infarction and hypertension was significantly higher in the non-resistant RT group than in the group of PC patients without ASA resistance (p < 0.05). These results may suggest that the elevated rate of aspirin resistance contributes to the high cardiovascular mortality after kidney transplantation.

      • KCI등재

        Aspirin resistance as cardiovascular risk after kidney transplantation

        Barbara Sandor,Adam Varga,Miklos Rabai,Andras Toth,Judit Papp,Kalman Toth,Peter Szakaly 한국유변학회 2014 Korea-Australia rheology journal Vol.26 No.2

        International surveys have shown that the leading cause of death after kidney transplantation has cardiovascularorigin with a prevalence of 35-40%. As a preventive strategy these patients receive aspirin (ASA)therapy, even though their rate of aspirin resistance is still unknown. In our study, platelet aggregation measurementswere performed between 2009 and 2012 investigating the laboratory effect of low-dose aspirin(100 mg) treatment using a CARAT TX4 optical aggregometer. ASA therapy was considered clinically effectivein case of low (i.e., below 40%) epinephrine-induced (10 μM) platelet aggregation index. Rate of aspirinresistance, morbidity and mortality data of kidney transplanted patients (n = 255, mean age: 49 ± 12 years)were compared to a patient population with cardio- and cerebrovascular diseases (n = 346, mean age: 52.6 ± 11years). Rate of aspirin resistance was significantly higher in the renal transplantation group (RT) compared tothe positive control group (PC) (35.9% vs. 25.6%, p < 0.002). Morbidity analysis demonstrated significantlyhigher incidence of myocardial infarction, hypertension and diabetes mellitus in the RT group (p < 0.05). Thesubgroup analysis revealed significantly higher incidence of infarction and stroke in the ASA resistant RTgroup compared to the RT patients without ASA resistance (p < 0.05). Furthermore, the incidence of myocardialinfarction and hypertension was significantly higher in the non-resistant RT group than in the groupof PC patients without ASA resistance (p < 0.05). These results may suggest that the elevated rate of aspirinresistance contributes to the high cardiovascular mortality after kidney transplantation.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼